Barely Significant
← all excerpts

Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)-Analysis of Data from Daily Practice.

Microorganisms · 2023 · PMC10459397 · PMID 37630558

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

marginally non-significantp = 0.053so close (0.05 < p ≤ 0.1)
In the multivariable analysis, a marginally non-significant interaction between the timing of remdesivir administration and baseline disease severity was observed ( p = 0.053, Table S1 ); the early administration of remdesivir in patients with a mild/moderate disease was associated with an indicative (HR: 0.20, 0.03–1.23; p = 0.083) decrease in the hazard of progression to the composite event, whereas there was no statistically significant difference in the patients with a severe disease ( p = 0.393).

also in 274 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.